Japan news brief
AI Drug Discovery: 143 Unapproved Drugs in Japan, Phase III in 47 Chinese Facilities
🇯🇵 JapanNEWS DESKPublisher image not supplied
NEWS DESKJapan
PUBLISHEDNov 2, 2026, 1:00 PM
What the source reports
The AI drug discovery candidate Rentosertib (Insilico) will proceed to Phase III in September 2026, and the figures in the post were generally consistent. However, the trial is being conducted at 47 ...
Main source: Bing News – Japan
TDBN presents the written preview supplied through the publisher's feed. Complete reporting, continuing updates, context, and corrections remain with the original report.
Read the complete report ↗